독서리서치레이더투자 프레임워크
로그인 / 회원가입
← 읽기로 돌아가기
뉴스주제 · AI药物警戒应用중대3 분 소요DisconfirmAI 편집부

US Mass General Brigham Team Develops AI Model That Predicts Cancer Death Risk from Face Photos

Researchers have developed FAHR-Face, an AI model that predicts cancer patients' survival risk by analyzing a single facial photograph. The model showed striking accuracy in tests, with high-scoring groups exhibiting significantly higher short-term mortality rates. Although not yet clinically deployed due to limited sample diversity, the technology promises to provide doctors with objective data for treatment decisions, while also raising ethical concerns about insurance and employment discrimination.

2026-10-20 06:30 GMT+8

Researchers at Mass General Brigham in the United States recently published a new study in The Lancet Digital Health introducing FAHR-Face, an artificial intelligence model capable of predicting a cancer patient's risk of dying from a single facial photograph. Led by radiation oncologist Ray Mak and his colleagues, the study aims to address the subjectivity inherent in traditional clinical assessments.

Mak noted that medical students are trained to form an impression of a patient's health by observing them, a 'clinical intuition' that directly influences treatment plans such as surgery, chemotherapy, or radiation. However, this assessment is inherently subjective. FAHR-Face attempts to convert this subjective impression into objective data. The team first allowed the algorithm to 'learn' from 40 million facial images without a specific task, then fine-tuned it to perform two functions: estimating biological age and predicting survival odds for cancer patients.

Test results revealed surprising accuracy. In a test group of 3,820 cancer patients, 64 out of the 122 individuals with the highest risk scores died within 90 days of having their photo taken, accounting for more than half. In a larger separate test group of over 38,000 cancer patients, those who appeared older than their chronological age also had a higher risk of dying. The researchers stated this is the first report of an AI algorithm that can directly predict cancer patient survival from a simple face photograph.

로그인 / 회원가입
독서리서치레이더투자 프레임워크

To understand how the AI makes these judgments, the team used 'attention mapping' to track where the algorithm focused during analysis. For age prediction, the AI primarily looked at areas like the nasolabial folds (the crease between the nose and mouth) and parts of the forehead. For death risk prediction, it tended to focus on the bridge of the nose and areas below the eyes. While it remains unclear why these specific areas correlate with death risk, the model appears to pick up on facial changes associated with known health risks like smoking and alcohol use. For instance, smokers and heavy drinkers often look older than their actual age. Expressions, makeup, and lighting had little effect on age predictions, but plastic surgery was an exception: people who had rhinoplasty were rated as slightly older in post-surgery photos compared to pre-surgery ones.

Despite its promise, FAHR-Face is not yet ready for clinical use. A major limitation is that the cancer survival model was trained on a Boston-area population that was majority white. The research team is working to expand their training sets to include a wider diversity of faces. Mass General Brigham has filed a patent for the face health algorithms.

The technology also raises ethical questions. Matthew Liao, a professor and director of the Center for Bioethics at New York University, commented that while such tools could help identify patients needing extra care, there is a risk of misidentification, potentially leading to withheld care for those who actually need it. Liao also expressed concern that insurance companies might use this technology to grant or deny coverage, or employers might use it to screen for 'healthier' job candidates. He argued that society must think through the implications before further development.

출처

  • scientificamerican.com↗
주제

AI药物警戒应用

人工智能正从实验室走向药物安全监测一线,成为捕捉传统临床试验难以发现的副作用信号的关键工具。2026年5月,美国宾夕法尼亚大学团队利用AI分析Reddit上逾40万条关于GLP-1减肥药(如Ozempic)的帖子,识别出月经异常、寒战等未被…

3 단계2 건업데이트됨 2026-10-21 04:51

현재까지의 과정

  1. 2026-05-24美国宾夕法尼亚大学研究团队在《Nature Health》发表成果,利用AI分析超过40万条Reddit帖子,发现GLP-1类药物用户频繁讨论月经不规则、寒战等未在临床试验中充分反映的症状。sciencedaily.com ↗
  2. 2026-10-20同一宾大团队在《JAMA Network Open》发文,展示AI如何扫描近15万条Reddit贴文,从未获批减肥药Retatrutide的使用反馈中提取出“食欲增加”这一与二期试验结果不同的副作用信号。technews.tw ↗
  3. 2026-10-20美国麻省总医院Brigham癌症研究所Ray Mak团队在《Lancet Digital Health》发布FAHR-Face模型,该模型可通过单张面部照片预测癌症患者死亡风险,但因训练集以白人为主且存在伦理争议,目前未投入临床。scientificamerican.com ↗

아직 해결되지 않은 문제

  • AI从社交媒体提取的信号如何转化为监管认可的正式安全性更新?
  • 面部照片预测模型在扩大种族多样性后,其临床准确性与伦理边界将如何界定?
  • 欧盟IHI拟议的AI药物警戒标准何时能形成具有约束力的指导文件?

이 스레드의 다른 내용

  • UPenn Team Uses AI to Scan Reddit for Unapproved Weight-Loss Drug Side Effects2026-10-20
전체 주제 읽기 →
리서치 계속하기 →